MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-01-0002265
Jonas Pharmaceuticals Private Limited - trading in Ambala, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹86.77 Lakh
▲ 12% YoY
Net profit · FY 2025
₹1 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹1.59 Lakh
EBITDA margin 1.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Jonas Pharmaceuticals Private Limited
Data last updated:
Jonas Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 26 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR2014PTC051994. Its GSTIN is 06AADCJ3121F1Z4 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arun Walia and Avi Walia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4307/25 Punjabi Mohalla, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹86.77 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹1 Lakh (net margin 1.2%) and EBITDA of ₹1.59 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
The company is associated with 1 brand: Jonas Pharmaceuticals. Court records list 3 cases involving the company, including 3 filed by the company.
Jonas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0002265). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jonaspharma.com.
Company details
CIN U24232HR2014PTC051994
Registration Number 051994
Incorporation Date 26 February 2014
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0002265
Key People
Arun Walia Director Avi Walia Director Recognitions & Rankings of Jonas Pharmaceuticals
Contact details
Jonas Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its website is jonaspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address4307/25 Punjabi Mohalla, Ambala Cantt, Haryana, India – 133001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Jonas Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Jonas Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Jonas Pharmaceuticals operates one associated brand: Jonas Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying pharmaceutical products in India. | jonaspharma.com |
Business activity
The main business activity of Jonas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Jonas Pharmaceuticals Private Limited, buy the company report.
Financials of Jonas Pharmaceuticals Private Limited
FY 2025 filings availableJonas Pharmaceuticals Private Limited reported revenue of ₹86.77 Lakh (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹86.77 Lakh ▲ 12%
Net profit · FY 2025
₹1 Lakh margin 1.2%
EBITDA · FY 2025
₹1.59 Lakh margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▼ 3%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 30%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 12% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jonas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jonas Pharmaceuticals Private Limited
Jonas Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Walia | Director | 20 Mar 2017 | 9 Years 7 Months | Current |
| Avi Walia | Director | 28 Jun 2023 | 3 Years 3 Months | Current |
Auditor
Jonas Pharmaceuticals Private Limited is audited by SHOBHIT BANSAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHOBHIT BANSAL & ASSOCIATES | FY 2017 | 021322N |
Shareholding
The shareholding of Jonas Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jonas Pharmaceuticals Private Limited, buy the company report.
Legal cases
Jonas Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Jonas Pharmaceuticals. All cases are disposed.
Total cases
3
Filed by the company
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Commercial suit | Filed by the company against M/S Arsh Enterprises | Disposed |
| District court, Ambala, Haryana | Commercial suit | Filed by the company against M/S Gynimede Health Care | Disposed |
| District court, Ambala, Haryana | Commercial suit | Filed by the company against an individual | Disposed |
To see the full case history of Jonas Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jonas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jonas Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCJ3121F1Z4 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jonas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jonas Pharmaceuticals Private Limited has 10 board changes on record since 2014: 6 appointments and 4 cessations. The latest: Jaspreet Kaur Nijhawan ceased to be Director on 05 Jul 2023.
AGM
Jonas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jonas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Jaspreet Kaur Nijhawan ceased to be Director.
Appointed
Avi Walia was appointed as Director.
Ceased
Puneet Mahajan ceased to be Director.
Ceased
Meenakshi Walia ceased to be Director.
Ceased
Tejinder Singh Nijhawan ceased to be Director.
Appointed
Arun Walia was appointed as Director.
Appointed
Jaspreet Kaur Nijhawan was appointed as Director.
Appointed
Meenakshi Walia was appointed as Director.
Appointed
Puneet Mahajan was appointed as Director.
Appointed
Tejinder Singh Nijhawan was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Jonas Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in other wholesale, within the trading industry. It was incorporated on 26 February 2014 (12+ years old) and is registered under CIN U24232HR2014PTC051994.
Jonas Pharmaceuticals has 2 current directors:
- Arun Walia - Director
- Avi Walia - Director
The latest financial statements of Jonas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jonas Pharmaceuticals is 06AADCJ3121F1Z4, registered in Haryana.
The CIN (Corporate Identification Number) of Jonas Pharmaceuticals is U24232HR2014PTC051994. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jonas Pharmaceuticals has 3 court cases on record: 3 filed by the company.
Jonas Pharmaceuticals was incorporated on 26 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Haryana.
Jaspreet Kaur Nijhawan ceased to be Director on 05 Jul 2023. Avi Walia was appointed as Director on 28 Jun 2023. Puneet Mahajan ceased to be Director on 27 Feb 2019. Jonas Pharmaceuticals has 10 board changes on record in total.
Yes, Jonas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0002265).
Jonas Pharmaceuticals can be reached through the website jonaspharma.com. Its registered office is in Ambala, Haryana, India.